Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study

NCT05761132 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Vulva Cancer
Vulva Neoplasm
Squamous Cell Cancer

Interventions

DRUG: Pembrolizumab

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]